Locations Set For Xarelto Lawsuit Trials Alleging The Blood Thinner Causes Uncontrolled Bleeding


Xarelto Lawsuit Claims Allege Patients Have Been Seriously And Fatally Injured By Significant Bleeding Events As A Result of Taking The Blood Thinner.

Xarelto-Lawsuits-Southern-Med-Law-AttorneyThe Xarelto lawsuit attorneys at Southern Med Law have learned that the first two bellwether trials for Xarelto bleeding side-effects complaints will be held in February 2017 at the U.S. District Court, Eastern District of Louisiana in New Orleans. The third bellwether trial will be held in Mississippi in April 2017 and the fourth trial will be held the following month in Texas at district courts to be named at a future date. The Xarelto lawsuits allege that Bayer and Janssen Pharmaceuticals, which makes and markets the blood thinner, failed to warn doctors and their patients about Xarelto’s potential to cause major bleeding events and there is no effective antidote to stop the bleeding.

U.S. District Judge Eldon Fallon, who is presiding over the Xarelto multidistrict litigation, recently released a Case Management Order (CMO) indicating that 40 Xarelto lawsuits will be selected as potential cases for bellwether trials. In the CMO, Judge Fallon directed attorneys for the plaintiffs and the defendants to each choose 10 potential cases for the bellwether pool and he will randomly select 20 cases. The parties will propose specific cases for trial by August 1, 2016. (In Re: Xarelto Products Liability Litigation, MDL No. 2592)

The Xarelto attorneys at Southern Med Law are evaluating Xarelto bleeding lawsuit claims and are offering free legal consultations to those who have suffered dangerous, uncontrolled bleeding allegedly, or those whose loved ones have died allegedly due to the use of the blood thinner Xarelto. Call 1-205-547-5525 or fill out our online form located on the www.southernmedlaw.com website.

Xarelto Complications: Xarelto is a oral blood thinner that received approval by the U.S. Food and Drug Administration (FDA) to reduce the risk of blood clots, pulmonary embolism, deep vein thrombosis, and to prevent stroke in patients with atrial fibrillation not caused by a heart valve problem. Xarelto is manufactured by Bayer Healthcare and marketed in the United States by Janssen Pharmaceuticals Inc. According to the FDA, the most common adverse reactions with Xarelto are bleeding complications yet Xarelto does not have a reversal agent to stop major bleeding. Warfarin, the oldest FDA-approved blood thinner on the market today, uses vitamin K as an antidote to stop bleeding events.
[fda.gov/Drugs/NewsEvents/ucm405148.htm, July 17, 2014]

According to Xarelto bleeding lawsuits, the blood thinner medication quickly became popular due to aggressive marketing of the drug and garnered $582 million in global sales in its first year. Xarelto soon reached blockbuster status after clearing $1 billion in sales and ultimately reaching $2 billion in 2013, according to the Xarelto complaints. The Xarelto lawsuits also state that the World Preview reported that Xarelto is estimated to be the “19th best-selling drug in the world by 2018,” with sales expected to jump from $596 million in 2012 to $3.7 billion in 2018. The Xarelto complaints contend that despite the predictions of enormous sales, the blockbuster drug continues to place patients at risk of severe bleeds and death. (In Re: Xarelto Products Liability Litigation, MDL No. 2592)

Xarelto Bleeding Lawsuit Claims: Court documents indicate that the Xarelto lawsuits continue to be filed in the multidistrict litigation (MDL) pending in the Eastern District of Louisiana. One lawsuit recently filed against Bayer and Janssen Pharmaceuticals involves a Maine woman who was prescribed Xarelto in June 2013. The complaint said the woman was admitted to the hospital about one year later for severe gastrointestinal bleeding and anemia which was allegedly caused by Xarelto. (Case No. 2:15-cv-01760) The Xarelto complaints in the MDL purport that Bayer and Janssen failed to warn about Xarelto’s potential for bleeding complications and there is no effective antidote to reverse the blood thinner’s effects.

About Southern Med Law And Filing Xarelto Bleeding Lawsuit Claim: Throughout his career, Dr. François Blaudeau, a founder of Southern Med Law, has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made Southern Med Law an aggressive and effective advocate for those who were harmed due to dangerous and defective drugs and medical devices. If you or a loved one experienced life-threatening Xarelto bleeding complications, please contact the Firm today to learn more about your legal rights. You can arrange for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

This entry was posted in Southern Med Law | Article. Bookmark the permalink.